Psychiatry & Neurology, Clinical Neurophysiology · Blue Bell, PA
NPI
1558495283
Since 2007
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
725 Skippack Pike, Parec Plaza, Suite 130
Blue Bell, PA, 19422
Phone (215) 591-0700
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
1,882 services
Medicare patients, 2024
154
Average age 66
Drug cost, 2024
$650K
2,144 prescriptions
Company payments, 2025
$1,339
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sonya M Knight was code 90833 (psychotherapy - nongroup), 396 times for 58 patients. In total Sonya M Knight billed 1,882 services in 24 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90833 Psychotherapy - Nongroup | Office | 396 | 58 | $55.42 | $22K |
| 99214 Office E&M - Established | Office | 395 | 99 | $96.84 | $38K |
| 99213 Office E&M - Established | Office | 261 | 84 | $64.96 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 241 | 77 | $13.11 | $3,161 |
| 99215 Office E&M - Established | Office | 108 | 45 | $138.29 | $15K |
| 99212 Office E&M - Established | Office | 93 | 37 | $38.76 | $3,605 |
| 90836 Psychotherapy - Nongroup | Office | 90 | 19 | $70.16 | $6,315 |
| 99443 Telephone Services | Office | 23 | 16 | $88.43 | $2,034 |
| 99205 Office E&M - New | Office | 15 | 15 | $180.34 | $2,705 |
By year: 2022 $109K for 1,463 services; 2023 $115K for 1,441 services; 2024 $148K for 1,882 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sonya M Knight prescribed most often to Medicare patients was Clonazepam, with 183 prescriptions and refills. In total Sonya M Knight wrote 2,144 Medicare prescriptions that cost $650K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 183 | 230 | 31 | $1,663 |
| Sertraline Hcl Generic | 161 | 341 | 36 | $1,934 |
| Duloxetine Hcl Generic | 112 | 252 | 27 | $3,799 |
| Lorazepam Generic | 93 | 113 | 17 | $745 |
| Gabapentin Generic | 78 | 126 | 16 | $871 |
| Fluoxetine Hcl Generic | 67 | 107 | 12 | $521 |
| Buspirone Hcl Generic | 65 | 125 | 18 | $728 |
| Trazodone Hcl Generic | 61 | 102 | 11 | $455 |
| Diazepam Generic | 59 | 65 | Under 11 | $610 |
| Lamotrigine Generic | 59 | 131 | 14 | $423 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 56 | 64 | Under 11 | $1,966 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 53 | 119 | 16 | $645 |
| Quetiapine Fumarate Generic | 53 | 81 | 11 | $954 |
| Alprazolam Generic | 44 | 75 | Under 11 | $448 |
| Temazepam Generic | 41 | 41 | Under 11 | $1,827 |
Brand drugs: 176 claims; generic drugs: 1,968 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sonya M Knight $1,339 ($1,339 in general payments such as food, travel and fees) from 11 companies. The largest payer was Brainsway USA INC with $685.
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC BWAY | 1 | $685 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $236 |
| Abbvie Inc. ABBV | 16 | $139 |
| Pfizer Inc. PFE | 3 | $71.91 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $47.21 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $37.99 |
| Collegium Pharmaceutical, Inc. COLL | 2 | $36.43 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $24.26 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $23.4 |
| Bausch Health US, LLC BHC | 1 | $19.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.